Form D · Pharmaceuticals
Pocket Naloxone Corp.
Bethesda, MD · CIK 0001847131
Offering snapshot reported Sep 2, 2021 · SEC filing
- Reported sold
- $6.16M Offering amount: $7.12M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 2, 2021 | Amendment | $6,163,967 | No comparison | Not reported | SEC filing |
| Feb 23, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-390228
Source: Form D, filed Sep 2, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrea Barthwell | Director |
| Kathryn Bowser | Director |
| Kathryn Bowsher | Director |
| Serena Kim | Executive |
| Ashanthi Mathai | Director, Executive |
| Behshad Sheldon | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4701 Sangamore Road
Bethesda, MD, 20816
Bethesda, MD, 20816